Ponatinib Advances as Frontline Therapy in Ph+ ALL: PhALLCON Study Highlights
Bijal Shah, MD, MS, and Hagop Kantarjian, MD, discuss promising results and regulatory progress for ponatinib in frontline Philadelphia-positive acute lymphoblastic leukemia treatment.
Bijal Shah Hagop Kantarjian Expert Insights Newly Diagnosed Frontline Therapy Acute Lymphoblastic Leukemia
Source: onclive.com